BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

World

Datasea Expands Acoustic AI Healthcare Robot Partnership To Accelerate Commercial Deployment

Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a technology company specializing in acoustic high-tech innovation and AI-driven multimodal...

March 09, 2026 | News

Insilico Medicine AI Discovered CKD Anemia Drug ISM4808 Enters Phase I Clinical Trial

Insilico Medicine (Insilico Medicine, HKEX: 03696), a clinical-stage biotechnology company powered by generative artificial intelligence (AI), announced th...

March 09, 2026 | News

Thermo Fisher Opens Cryo Electron Microscopy Drug Discovery Center In South San Francisco

Thermo Fisher Scientific, the world leader in serving science, today announced the opening of its Cryo-Electron Microscopy (cryo-EM) Drug Discovery Center ...

March 06, 2026 | News

Sino Biological Launches 2026 To 2027 Influenza Vaccine Strain Antigens Following WHO Recommendations

The World Health Organization (WHO) has announced its recommendations for the 2026–2027 Northern Hemisphere influenza vaccine composition, highlighti...

March 06, 2026 | News

Akeso Reports Durable Long Term Survival Benefit Of Cadonilimab In Advanced Cervical Cancer

Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced that the latest long-term survival analysis data from the China pivotal registrational Phase II ...

March 06, 2026 | Report

Insilico Medicine And Liquid AI Introduce Lightweight Foundation Model For End To End Drug Discovery

Single 2.6B-parameter model achieves state-of-the-art performance across drug discovery benchmarks while running entirely on private pharmaceutical in...

March 05, 2026 | News

ISCT And JSRM Form Five Year Global Partnership To Accelerate Clinical iPSC Therapies

The International Society for Cell & Gene Therapy (ISCT), the translation-focused global community of cell and gene therapy experts and the Japanese So...

March 05, 2026 | News

XellSmart Secures Fourth Dual US And China Regulatory Clearance For iPSC Derived Cell Therapy In Multiple System Atrophy

XellSmart Pharmaceutical Co., Ltd. (XellSmart) announced that it had secured its fourth US FDA and China NMPA clearance for P...

March 04, 2026 | News

XtalPi And ReviR Dose First Participant In Phase One Trial Of RTX 117 For Rare Neurological Disorders

RTX-117 is an investigational small molecule designed to modulate the Integrated Stress Response (ISR) pathway, with the goal of restoring protein transl...

March 04, 2026 | News

Thermo Fisher Launches Chromogenic Candida Media To Strengthen AMR Detection In Clinical Laboratories

Brilliance Candida 2 Agar and Spectra Candida Agar support earlier detection, faster outbreak response and more informed treatment decisions in healthcare ...

March 03, 2026 | News

Thermo Fisher Launches TacroType Pharmacogenetic Test To Personalise Tacrolimus Dosing In Transplant Care

TacroType™ Pharmacogenetic Test designed to support more personalized tacrolimus dosing, assisting clinical decision-making in solid organ ...

March 03, 2026 | News

Takeda And Protagonist Secure FDA Priority Review For Rusfertide In Polycythemia Vera

Rusfertide Demonstrated Significant Improvements in Hematocrit Control, Phlebotomy Reduction and Patient Reported Outcomes for Patients with Polycythem...

March 03, 2026 | News

Pfizer And Astellas Report Strong Phase III EV 304 Results For PADCEV Plus Pembrolizumab In MIBC

In the Phase 3 EV-304 trial, statistically significant improvements in overall survival and pathological complete response were also observed, with ove...

March 02, 2026 | News

SystImmune And Bristol Myers Squibb Report Dual PFS And OS Success For Iza Bren In Phase III TNBC Trial

Izalontamab brengitecan (Iza-bren) met its dual primary endpoints of progression free survival (“PFS”) and overall survival (“OS”...

March 02, 2026 | News

Stay Connected